Greg Tourangeau
Principal Accounting Officer · 1 filing · Latest: Feb 2, 2026
Fulcrum Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
FULC | Greg Tourangeau | — | Sep 2, 2026 | Proposed Sale | $3.87 | 14,062 | $54.4K | — |